Global Pharmaceutical Excipients Market
The global pharmaceutical excipients market is expected to grow from $8.3 billion in 2021 to $10.6 billion by 2030, at a compound annual growth rate (CAGR) of 5.0% for the period of 2021-2030.
Pharmaceutical excipients considered to be inert substances, other than the pharmacologically active drug, which are included in the manufacturing process or are present in the pharmaceutical product dosage form. Excipients are widely used in drug formulation to provide long-term stability, add bulkiness to solid formulations and facilitate drug absorption. They has a physical property to enhance the overall safety or functionality of the product during storage or use.
The amalgamation of drug formulation and nanotechnology in excipients have led to the development of nano-coated tablets, nano-derived liposomes, and vaccines. Furthermore, several companies have targeted the emerging economies for expansion of their plants for manufacturing pharmaceutical excipients, preservatives, glycerin and Fatty Acids owing to cost-effective labor.
Market Drivers
Increasing uptake of biopharmaceuticals can drive the market growth, since they are moderately becoming popular in the industry because of being similar to natural biological compounds found in the human body; thus, they offer high efficacy and fewer side-effects. The efficacy and safety associated with biopharmaceutical products, combined with their ability to address previously untreatable conditions, allows pharmaceutical companies to command high prices for innovative drugs, thus contributing significantly to their overall revenue.
Market Restraints
Restraining factor for the market is cost and time – intensive drug development process. Late-stage failures in the drug development process increase R&D costs which causes impact on the profit margins of pharmaceutical companies. Thus, although excipient and drug production have seen significant advances in recent years, the requirement of high capital investments is expected to hamper market growth during the forecast period.
Market Segmentation
Globally market is bifurcated into product segmentation and formulations segmentation. Product segmentation is divided into organic and inorganic chemicals. Organic segment is expected to grow at highest CAGR during the forecast period whereas the other segment is still growing in the market. Formulations segment is classified into oral, topical and parental formulations. Oral formulations dominate the market due to their wide usage and efficacy against many ailments whereas the anticipated growth of the topical drug which was reinforced by many factors, is expected to push the segment to surpass those of oral drug delivery methods.
Regional Analysis
Globally, Pharmaceutical Excipients market can be classified into North America, Europe, Asia Pacific (APAC), Middle East and Africa, China and Latin America. Europe is expect to account for largest share in the market, Many European countries are focusing their attention on the generics market due to the expiration of blockbuster drug patents in the coming years. The North America is the leading revenue-generating region, due to growing demand for solid oral drugs for the treatment of chronic diseases. Furthermore, the Asia-Pacific region is expected to register the highest CAGR, owing to low cost of raw materials and availability of cost-effective workforce.
Key Players
The global pharmaceutical excipients market key players are Ashland., Roquette Frères, Evonik Industries AG, Dow, Croda International Plc BASF SE, Avantor, Inc, BENEO, Chemische Fabrik Budenheim, Kerry Inc., DFE Pharma, Colorcon, Air Liquide, The Lubrizol Corporation, Archer Daniels Midland Company Associated British Foods plc, Peter Greven GmbH & Co. KG and Pfanstiehl, Inc.
Industry development
In May 2019, Ashland announced the launch of Aquarius Nutra TF, which provides titanium oxide-based coating to tablets in the European market.
Global Diamond Market Segmentation
Product Outlook
Formulations Outlook
By region
Key Questions Addressed by the Report?
Global Pharmaceutical Excipients Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Pharmaceutical Excipients Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
5 Global Pharmaceutical Excipients Market, By Product
5.1 Y-o-Y Growth Comparison, By Formulations
5.2 Global Pharmaceutical Excipients Market Share Analysis, By Product
5.3 Global Pharmaceutical Excipients Market Size and Forecast, By Product
5.3.1. Organic chemicals
5.3.2. Inorganic chemicals
6 Global Pharmaceutical Excipients Market, By Formulations
6.1 Y-o-Y Growth Comparison, By Formulations
6.2 Global Pharmaceutical Excipients Market Share Analysis, By Formulations
6.3 Global Pharmaceutical Excipients Market Size and Forecast, By Formulations
6.3.1 Oral formulations
6.3.2 Topical formulations
6.3.3 Parenteral formulations
7. Global Pharmaceutical Excipients, By Region
7.1 Global Pharmaceutical Excipients Market Share Analysis, By Region
7.2 Global Pharmaceutical Excipients Market Share Analysis, By Region
7.3 Global Pharmaceutical Excipients Market Size and Forecast, By Region
8. North America Pharmaceutical Excipients Market Analysis and Forecast (2021- 2030)
8.1 Introduction
8.2 North America Pharmaceutical Excipients Market Share Analysis, By Product
8.3 North America Pharmaceutical Excipients Market Size and Forecast, By Formulation
8.4 North America Pharmaceutical Excipients Market Size and Forecast, By Country
8.5.1 U.S.
8.4.2 Canada
8.4.3 Mexico
9. Europe Pharmaceutical Excipients Market Analysis and Forecast (2021-2030)
9.1 Introduction
9.2 Europe Pharmaceutical Excipients Market Share Analysis, By Product
9.3 Europe Pharmaceutical Excipients Market Size and Forecast, By formulations
9.5 Europe Pharmaceutical Excipients Market Size and Forecast, By Country
9.5.1 Germany
9.5.2 France
9.5.3 UK
9.54. Rest of Europe
10. Asia Pacific Pharmaceutical Excipients Market Analysis and Forecast (2021-2030)
10.1 Introduction
10.2 Asia Pacific Pharmaceutical Excipients Market Share Analysis, By Product
10.3 Asia Pacific Pharmaceutical Excipients Market Size and Forecast, By Formulations
10.5 Asia Pacific Pharmaceutical Excipients Market Size and Forecast, By Country
10.5.1 China
10.5.2 Japan
10.5.3 India
10.5.4. Rest of Asia Pacific
11. Latin America Pharmaceutical Excipients Market Analysis and Forecast (2021-2030)
11.1 Introduction
11.2 Latin America Pharmaceutical Excipients Market Share Analysis, By
Product
11.3 Latin America Pharmaceutical Excipients Market Size and Forecast, By Formulations
11.5 Latin America Pharmaceutical Excipients Market Size and Forecast, Country
11.5.1. Brazil
11.5.2. Rest of Latin America
12. Middle East Pharmaceutical Excipients Market Analysis and Forecast (2021-2030)
12.1 Introduction
12.2 Middle East Pharmaceutical Excipients Market Share Analysis, By Product
12.3 Middle East Pharmaceutical Excipients Market Size and Forecast, By Formulations
12.5 Middle East Pharmaceutical Excipients Market Size and Forecast, By Country
12.5.1. Saudi Arabia
12.5.2. UAE
12.5.3. Egypt
12.5.4 Kuwait
12.5.5. South Africa
13 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
14 Company Profiles
14.1 Ashland
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2. Roquette Frères
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3. Evonik Industries AG
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 Dow
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 Croda International Plc
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 BASF SE
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Avantor, Inc
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 BENEO
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Chemische Fabrik Budenheim
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Kerry Inc
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
15.11 DFE Pharma
15.11.1 Overview
15.11.2 Offerings
15.11.3 Key Financials
15.11.4 Business Segment & Geographic Overview
15.11.5 Key Market Developments
15.11.6 Key Strategies
15.12 Colorcon
15.12.1 Overview
15.12.2 Offerings
15.12.3 Key Financials
15.12.4 Business Segment & Geographic Overview
15.122.5 Key Market Developments
15.12.6 Key Strategies
15.13 Air Liquide
15.13.1 Overview
15.13.2 Offerings
15.13.3 Key Financials
15.13.4 Business Segment & Geographic Overview
15.13.5 Key Market Developments
15.13.6 Key Strategies
15.14 The Lubrizol Corporation
15.14.1 Overview
15.14.2 Offerings
15.14.3 Key Financials
15.14.4 Business Segment & Geographic Overview
15.14.5 Key Market Developments
15.14.6 Key Strategies
15.15 Archer Daniels Midland Company
15.15.1 Overview
15.15.2 Offerings
15.15.3 Key Financials
15.15.4 Business Segment & Geographic Overview
15.15.5 Key Market Developments
15.15.6 Key Strategies
15.16 Associated British Foods plc
15.16.1 Overview
15.16.2 Offerings
15.16.3 Key Financials
15.16.4 Business Segment & Geographic Overview
15.16.5 Key Market Developments
15.16.6 Key Strategies
15.17 Peter Greven GmbH & Co. KG
15.17.1 Overview
15.17.2 Offerings
15.17.3 Key Financials
15.17.4 Business Segment & Geographic Overview
15.17.5 Key Market Developments
15.17.6 Key Strategies
15.18 Pfanstiehl, Inc
15.18.1 Overview
15.18.2 Offerings
15.18.3 Key Financials
15.18.4 Business Segment & Geographic Overview
15.18.5 Key Market Developments
15.18.6 Key Strategies
